BARTLETT & CO. WEALTH MANAGEMENT LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2010186
CINCINNATI, OH
Position in VRTX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$254,527
-$17,942 QoQ
Shares Held
570
-5.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 64.91228070175438.ToString("F0")%
Shared 0.ToString("F0")%
None 35.08771929824561.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARTLETT & CO. WEALTH MANAGEMENT LLC holds $1,178,544 across 17 Biotechnology names. VRTX ranks #3 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,100 | $528,027 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
362 | $279,695 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
570 | $254,527 | |
| 4 | INCY |
Incyte Corp
|
354 | $33,318 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
1,500 | $28,800 | |
| 6 | CADL |
Candel Therapeutics, Inc.
|
3,520 | $17,248 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
1,071 | $10,088 | |
| 8 | OCGN |
Ocugen, Inc.
|
5,300 | $9,593 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $254,527 | 570 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $272,469 | 601 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $234,984 | 600 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $261,332 | 587 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $284,589 | 587 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $143,763 | 357 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $166,033 | 357 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $164,520 | 351 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $106,592 | 255 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $81,378 | 200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $69,548 | 200 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $70,382 | 200 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $63,014 | 200 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $57,756 | 200 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $57,908 | 200 | Shares | Sole | 2024-02-14 | |
| 2022-06-30 | $56,358 | 200 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $52,194 | 200 | Shares | Sole | 2024-02-14 | |
| 2021-06-30 | $806 | 4 | Shares | Sole | 2024-02-14 | |
| 2021-03-31 | $11,604 | 54 | Shares | Sole | 2024-02-14 | |
| 2020-12-31 | $12,762 | 54 | Shares | Sole | 2024-02-13 | |
| 2020-09-30 | $13,606 | 50 | Shares | Sole | 2024-02-13 | |
| 2020-06-30 | $14,515 | 50 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||